Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RMD · against 84 other Healthcare companies of similar size
Ranked #22 of 85 · scores higher than 75% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)6 peers with a safety percentile of 50–59, including RMD · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 82 reported | 0.13× | 0.46× | 77% | 33% | |
| BetaLower is better · 81 reported | 0.77 | 0.77 | 50% | 33% | |
| Current ratioHigher is better · 81 reported | 3.10× | 1.80× | 80% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 18 | 67.60T KRW (≈$48.7B) | 64 | 72 | |
| 19 | 40.2B USD | 62 | 73 | |
| 20 | 6.17T JPY (≈$42.0B) | 61 | 70 | |
| 21 | 16.8B USD | 59 | 75 | |
| 22 | 32.8B USD | 59 | 69 | |
| 23 | 3.53T JPY (≈$24.0B) | 58 | 68 | |
| 24 | 43.30T KRW (≈$31.2B) | 55 | 68 | |
| 25 | 52.7B EUR (≈$58.0B) | 52 | 71 | |
| 26 | 5.26T JPY (≈$35.8B) | 51 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score